CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.An injection pen for Zepbound, which Caremark intends to stop offering in July.
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
Scritto il 12/05/2025
da Rebecca Robbins and Reed Abelson